She previously worked with Merck Research Laboratories (MRL), joining the company in 1987 and retiring from the position of vice president for lead optimization chemistry in 2015.

She has received a number of awards, including the Perkin Medal (2017) and has been inducted into the ACS Division of Medicinal Chemistry’s MEDI Hall of Fame.

Ann Weber took part in a summer internship for Monsanto from June 1982-August 1982 where she studied the synthesis of novel herbicides for crop protection.

[8] Weber joined Merck Research Laboratories (MRL) in Rahway, New Jersey, in 1987, retiring in 2015 from the position of vice president for lead optimization chemistry.

[11] Beginning in 1999, Weber led the chemical team for the development of Januvia (generic: sitagliptin), a drug that inhibits the dipeptidyl peptidase-4 (DPP-4) enzyme and improves glucose tolerance to treat Type 2 diabetes.